← back to search

Elana J. Fertig

Genetic Resources Center · US
Area of research
Immunology · Oncology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Immune cells in cancer, Phagocytosis and Immune Regulation, and Cancer Genomics and Diagnostics.
h-index
54
citations
11,584
works
915
NIH funding
primary concept
Medicine
email

Recent publications

Human interpretable grammar encodes multicellular systems biology models to democratize virtual cell laboratories
Cell 2025cited by 37position: middledoi
Advancing biological understanding of cellular senescence with computational multiomics
Nature Genetics 2025cited by 21position: middledoi
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
Nature Medicine 2024cited by 209position: middledoi
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial
Nature Cancer 2024cited by 46position: middledoi
Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial–Mesenchymal Transition and Inflammation in Cancer Cells in Pancreatic Ductal Adenocarcinoma
Cancer Research 2024cited by 44position: middledoi
Ten challenges and opportunities in computational immuno-oncology
Journal for ImmunoTherapy of Cancer 2024cited by 10position: middledoi
Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence
Genome Medicine 2023cited by 122position: middledoi
Transfer learning in a biomaterial fibrosis model identifies in vivo senescence heterogeneity and contributions to vascularization and matrix production across species and diverse pathologies
GeroScience 2023cited by 62position: middledoi
Inferring cellular and molecular processes in single-cell data with non-negative matrix factorization using Python, R and GenePattern Notebook implementations of CoGAPS
Nature Protocols 2023cited by 23position: middledoi
Morphology-guided transcriptomic analysis of human pancreatic cancer organoids reveals microenvironmental signals that enhance invasion
Journal of Clinical Investigation 2023cited by 22position: middledoi
Triple-negative breast cancer metastasis involves complex epithelial-mesenchymal transition dynamics and requires vimentin
Science Translational Medicine 2022cited by 193position: middledoi
Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy
Cancer Cell 2022cited by 177position: middledoi
Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity
Nature Cancer 2021cited by 342position: middledoi
A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy
Nature Cancer 2021cited by 293position: middledoi
From bench to bedside: Single-cell analysis for cancer immunotherapy
Cancer Cell 2021cited by 131position: middledoi
Computational reconstruction of the signalling networks surrounding implanted biomaterials from single-cell transcriptomics
Nature Biomedical Engineering 2021cited by 130position: middledoi
Single-Cell Analysis of Human Retina Identifies Evolutionarily Conserved and Species-Specific Mechanisms Controlling Development
Developmental Cell 2020cited by 303position: middledoi
Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic Cancer
Clinical Cancer Research 2020cited by 149position: middledoi
A Phase II Study of Allogeneic GM-CSF–Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer
Clinical Cancer Research 2020cited by 125position: middledoi
HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers
Oncogene 2020cited by 98position: middledoi
Single-Cell RNA-Seq Analysis of Retinal Development Identifies NFI Factors as Regulating Mitotic Exit and Late-Born Cell Specification
Neuron 2019cited by 612position: middledoi
Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival
Cancer Immunology Research 2019cited by 262position: middledoi
Aging-like Spontaneous Epigenetic Silencing Facilitates Wnt Activation, Stemness, and BrafV600E-Induced Tumorigenesis
Cancer Cell 2019cited by 190position: middledoi
Decomposing Cell Identity for Transfer Learning across Cellular Measurements, Platforms, Tissues, and Species
Cell Systems 2019cited by 184position: lastdoi
Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers
Nature Communications 2019cited by 109position: middledoi
Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic Progression
Cancer Research 2019cited by 85position: middledoi
Publisher Correction: Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers
Nature Communications 2019cited by 9position: middledoi
Enter the Matrix: Factorization Uncovers Knowledge from Omics
Trends in Genetics 2018cited by 264position: lastdoi
Epigenetic regulation of gene expression in cancer: techniques, resources and analysis
Briefings in Functional Genomics 2017cited by 136position: lastdoi
SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells
Clinical Cancer Research 2017cited by 76position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Elizabeth M. Jaffee · NYU Langone Health7 papers (2019–2024)Daria A. Gaykalova · Thomas Jefferson University7 papers (2013–2020)Genevieve Stein-O’Brien · Convergence7 papers (2017–2023)Alexander V. Favorov · Johns Hopkins Medicine7 papers (2014–2020)Ludmila Danilova · Convergence6 papers (2013–2023)Luciane T. Kagohara · Bloomberg (United States)5 papers (2015–2024)David Sidransky · Mitra Biotech (India)5 papers (2013–2017)Daniel A. Laheru · NYU Langone Health4 papers (2019–2021)Loyal A. Goff · Johns Hopkins University4 papers (2018–2023)Nishant Agrawal · Institute of Chartered Financial Analysts of India4 papers (2013–2016)William H. Westra · Moffitt Cancer Center4 papers (2013–2017)Christine H. Chung · Diabetes & Endocrine Associates4 papers (2013–2017)Pablo Tamayo · University of San Diego4 papers (2019–2023)Theresa Guo · National Foundation for Cancer Research4 papers (2017–2020)Michael Considine · The University of Western Australia4 papers (2014–2020)Wayne M. Koch · Johns Hopkins University3 papers (2014–2020)Emily F. Davis-Marcisak · Bloomberg (United States)3 papers (2019–2023)Won Jin Ho · Bloomberg (United States)3 papers (2019–2021)Thomas D. Sherman · Johns Hopkins University3 papers (2019–2023)Kathleen M. Fisch · Center for Genomic Science3 papers (2019–2020)